EUVIMEDEUVIMED entdecken
Open Access

Comparative Analysis of C-reactive Protein and Procalcitonin as Biomarkers for Prognostic Assessment in Pediatric Sepsis

Neha Tyagi, Siddhi Gawhale, Manojkumar G Patil, Sampada Tambolkar, Shradha Salunkhe, Shailaja V Mane

Cureus · 26.07.2024

DOI: 10.7759/cureus.65427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 26.07.2024. Verfasst von Neha Tyagi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University) Pimpri, Pune, IND. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

biomarkersc-reactive proteinpediatricprocalcitoninprognostic utilitysepsis

Autor:innen und Institutionen

  • Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University) Pimpri, Pune, IND.

Zitieren

APA

Tyagi, N., Gawhale, S., Patil, M. G., Tambolkar, S., Salunkhe, S., & Mane, S. V. (2024). Comparative Analysis of C-reactive Protein and Procalcitonin as Biomarkers for Prognostic Assessment in Pediatric Sepsis. Cureus. https://doi.org/10.7759/cureus.65427

Vancouver

Tyagi N, Gawhale S, Patil MG, Tambolkar S, Salunkhe S, Mane SV. Comparative Analysis of C-reactive Protein and Procalcitonin as Biomarkers for Prognostic Assessment in Pediatric Sepsis. Cureus. 2024. doi:10.7759/cureus.65427

BibTeX
@article{Tyagi2024,
  author = {Tyagi, Neha and Gawhale, Siddhi and Patil, Manojkumar G and Tambolkar, Sampada and Salunkhe, Shradha and Mane, Shailaja V},
  title = {Comparative Analysis of C-reactive Protein and Procalcitonin as Biomarkers for Prognostic Assessment in Pediatric Sepsis},
  journal = {Cureus},
  year = {2024},
  doi = {10.7759/cureus.65427}
}
Kostenlos starten →